Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma

NCT06497738

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Changzhou Second People's Hospital Changzhou, Jiangsu, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • Nanjing First People's Hospital Nanjing, Jiangsu, China
  • Affiliated Hospital of Nantong University Nantong, Jiangsu, China
View Trial Details
Recruiting

Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

NCT05565807

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Beijing Chao-Yang Hospital，Capital Medicine University Beijing, Beijing Municipality, China
  • Peking university Third hospital Beijing, Beijing Municipality, China
  • The first affiliated hospital ,Sun Yat-sen University Guangzhou, Guangdong, China
  • The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Recruiting

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

NCT04315324

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • PCR Oncology Arroyo Grande, California, United States
View all 163 locations
View Trial Details
Recruiting

A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma

NCT07124936

Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Peking University Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • The Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi, China
View all 21 locations
View Trial Details
Recruiting

Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL

NCT05583071

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Klinikum Stuttgart - Katharienenhospital Stuttgart, Baden-Wurttemberg, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Würtemberg, Germany
  • University of Cologne Cologne, Germany
  • Universitätsklinikum Hamburg-Eppendorf Hamburg, Hamurg, Germany
View Trial Details

Related conditions